Quarterly Results

KDL BIOTECH LTD.

NSE : NABSE : 532291ISIN CODE : INE746A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE2.140 (0 %)
PREV CLOSE ( ) 2.14
OPEN PRICE ( ) 2.14
BID PRICE (QTY) 2.14 (584)
OFFER PRICE (QTY) 2.36 (1)
VOLUME 4811
TODAY'S LOW / HIGH ( )2.14 2.14
52 WK LOW / HIGH ( ) 2.142.14
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
NA
0.00
0.00
0.00
Total Expenditure
3.37
3
3.08
11.72
PBIDT (Excl OI)
-3.37
-3
-3.08
-11.72
Other Income
0.17
0.37
0.36
1.32
Operating Profit
-3.2
-2.63
-2.72
-10.4
Interest
12.72
12.31
12.18
16.91
Exceptional Items
NA
NA
NA
NA
PBDT
-15.92
-14.94
-14.9
-27.31
Depreciation
17.35
17.38
17.19
17.02
Profit Before Tax
-33.27
-32.32
-32.09
-44.33
Tax
NA
0.00
0.00
0.00
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-33.27
-32.32
-32.09
-44.33
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-33.27
-32.32
-32.09
-44.33
Equity Capital
240.35
240.35
240.35
240.35
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-1.38
-1.34
-1.33
-1.84
Calculated EPS (Annualised)
-5.53
-5.37
-5.34
-7.37
No of Public Share Holdings
7485241
7485241
7485241
7485241
% of Public Share Holdings
31.14
31.14
31.14
31.14
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
NA
NA
NA
PBIDTM%
NA
NA
NA
NA
PBDTM%
NA
NA
NA
NA
PBTM%
NA
NA
NA
NA
PATM%
NA
NA
NA
NA
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.